Effects of schizophrenomimetics on the expression of the CCN1 (CYR 61) gene encoding a matricellular protein in the infant and adult neocortex of the mouse and rat

International Journal of Neuropsychopharmacology

Volumn 10, Issue 6, 2007, Pages 717-725

  Ito, Takashi ^a   Hiraoka, Shuichi ^a   Kuroda, Yasukazu ^a   Ishii, Sumikazu ^a   Umino, Asami ^a   Kashiwa, Atsushi ^a   Yamamoto, Naoki ^a   Kurumaji, Akeo ^a   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CCN1 gene expression; Dizocilpine; Methamphetamine; Neocortex phencyclidine; Postnatal development

Indexed keywords

CELL PROTEIN; CYSTEINE RICH PROTEIN 61; DIZOCILPINE; PHENCYCLIDINE; PSYCHOSTIMULANT AGENT; SCHIZOPHRENOMIMETIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CCN1 GENE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; MOUSE; NEOCORTEX; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; UPREGULATION;

ANIMALS; BLOTTING, NORTHERN; DNA; DOWN-REGULATION; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NEOCORTEX; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENCYCLIDINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; UP-REGULATION;

EID: 35648930881     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707007882     Document Type: Article

References (33)

1. Albrecht C, von Der Kammer H, Mayhaus M, Klaudiny J, Schweizer M, Nitsch RM (2000). Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61. Journal of Biological Chemistry 275, 28929-28936.
2. APA (2000). Schizophrenia and other psychotic disorders. In: Diagnostic and Statistical Manual of Mental Disorders (4th edn) (pp. 297-343). Washington, DC: American Psychiatric Association.
3. Castello R, Estelles A, Vazquez C, Falco C, Espana F, Almenar SM, Fuster C, Aznar J (2002). Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Clinical Chemistry 48, 1288-1295.
4. Chung KC, Ahn YS (1998). Expression of immediate early gene cyr61 during the differentiation of immortalized embryonic hippocampal neuronal cells. Neuroscience Letters 255, 155-158.
5. Deutch AY, Tam SY, Freeman AS, Bowers Jr. MB, Roth RH (1987). Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. European Journal of Pharmacology 134, 257-264.
6. Hashimoto T, Kajii Y, Nishikawa T (1998). Psychotomimetic- induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. European Journal of Pharmacology 10, 3387-3399.
7. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148, 1301-1308.
8. Kajii Y, Muraoka S, Hiraoka S, Fujiyama K, Umino A, Nishikawa T (2003). A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. Molecular Psychiatry 8, 434-444.
9. Kashiwa A, Nishikawa T, Nishijima K, Umino A, Takahashi K (1995). Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. Neurochemistry International 26, 269-279.
10. Kim KH, Min YK, Baik JH, Lau LF, Chaqour B, Chung KC (2003). Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor. Journal of Biological Chemistry 278, 13847-13854.
11. Kireeva ML, MO FE, Yang GP, Lau LF (1996). Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Molecular and Cellular Biology 16, 1326-1334.
12. Kolesnikova TV, Lau LF (1998). Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16, 747-754.
13. McCann UD, Ricaurte GA (2004). Amphetamine neurotoxicity: accomplishments and remaining challenges. Neuroscience and Biobehavioral Reviews 27, 821-826.
14. Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, Noda Y, Nitta A, Nabeshima T (2004). The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proceedings of the National Academy of Sciences USA 101, 3650-3655.
15. Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa T (1996). Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22, 304-312.
16. Nishijima K, Kashiwa A, Nishikawa T (1994). Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor. Journal of Neurochemistry 63, 375-378.
17. O'Brien TP, Yang GP, Sanders L, Lau LF (1990). Expression of cyr61, a growth factor-inducible immediate-early gene. Molecular and Cellular Biology 10, 3569-3577.
18. Olney JW, Labruyere J, Price MT (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
19. Perez-Navarro E, Alberch J, Marsal J (1993). Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices. Effect of 6-hydroxydopamine lesion. International Journal of Developmental Neuroscience 11, 701-708.
20. Rachfal AW, Brigstock DR (2005). Structural and functional properties of CCN proteins. Vitamins and Hormones 70, 69-103.
21. Reich DL, Silvay G (1989). Ketamine: an update on the first twenty-five years of clinical experience. Canadian Journal of Anaesthesia 36, 186-197.
22. Sato D, Umino A, Kaneda K, Takigawa M, Nishikawa T (1997). Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain. Neuroscience Letters 239, 21-24.
23. Scalzo FM, Burge LJ (1994). The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology 15, 191-200.
24. Scalzo FM, Holson RR (1992). The ontogeny of behavioral sensitization to phencyclidine. Neurotoxicology and Teratology 14, 7-14.
25. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K (1994). Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. Journal of Pharmacology and Experimental Therapeutics 269, 1040-1048.
26. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A, Heinen E (1999). Housekeeping genes as internal standards: use and limits. Journal of Biotechnology 75, 291-295.
27. Toth E, Lajtha A (1986). Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochemical Research 11, 393-400.
28. Umino A, Nishikawa T, Takahashi K (1995). Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochemistry International 26, 85-90.
29. Umino A, Takahashi K, Nishikawa T (1998). Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. British Journal of Pharmacology 124, 377-385.
30. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berlin) 151, 99-120.
31. Watanabe M, Inoue Y, Sakimura K, Mishina M (1992). Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3, 1138-1140.
32. White PF, Way WL, Trevor AJ (1982). Ketamine - its pharmacology and therapeutic uses. Anesthesiology 56, 119-136.
33. Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR, Vainer M, Johnston R (2001). An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Research 29, E41-1.